Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-{[5-(Cyclohexyloxy)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This compound is a synthetic small molecule belonging to the class of benzenesulfonamides and triazolopyrimidines. It is identified as an experimental drug with no approved therapeutic indications or established mechanism of action. The molecule has been referenced in chemical and biological databases (e.g., DrugBank DB07688; CHEMBL203407; PubChem CID 11574606), but there is no evidence of clinical development or marketing approval. Its primary use appears to be in research settings for studying structure–activity relationships within the triazolopyrimidine scaffold.[1][2][8]
- Other names
- 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE4-((5-(Cyclohexyloxy)(1,2,4)triazolo(1,5-A)pyrimidin-7-YL)amino)benzenesulfonamidetriazolo[1,5-a]pyrimidine 6
02
Targets
CDK2 (Cyclin-dependent kinase 2)GSK3 (Glycogen synthase kinase 3 beta)
Beyond the preview
Go deeper on 4-{[5-(Cyclohexyloxy)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-{[5-(Cyclohexyloxy)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide.